Dr. Shah is a top deputy to FDA Commissioner Stephen Hahn, MD. In his role, Dr. Shah has worked on several initiatives related to the pandemic, including developing the FDA’s Pandemic Recovery and Preparedness Plan, which will assess the agency’s COVID-19 response and decision-making.
Dr. Shah, a radiation oncologist, also served as CMO of CMS’ Innovation Center and as CMS Administrator Seema Verma’s senior medical adviser for innovation.
Read more here.
More articles on leadership and management:
Wyoming hospital CEO says state not getting fair share of vaccines
4 leadership changes CEOs made during the pandemic
AHA writes letter urging HHS to expedite vaccination process
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
